ZENTIVA
86 articole · RSS
Drugmaker Zentiva Wants to Join “Billionaires’ League” in 2024
Drugmaker Zentiva has budgeted net revenues of above RON1.1 billion in 2024, up 20% from 2023 level, which would mark the company’s joining the RON billionaires’ league.
Production Expansion and Launch of New Products, Zentiva Romania’s Targets for Next 10 Years
Zentiva Romania’s objectives for the next decade envisage expanding production at the two plants it owns in Bucharest and adding new products to its portfolio.
Drugmaker Zentiva Sees Net Profit Quadruple To RON124M In Jan-Sep
Drugmaker Zentiva (SCD) posted RON124 million net profit in the first nine months of 2023, compared with RON33.6 million in the same period last year, while revenue rose to RON684 million fr...
Zentiva Turnover Up 24% YoY To RON450M In H1/2023
Zentiva (SCD.RO), one of the largest pharmaceutical companies in Romania, had a turnover of RON450.6 million in the first six months of 2023, up 24% from the same period in 2022.
Zentiva Sees Ninefold Increase In Q1 Profit To Over RON42M
Pharmaceutical company Zentiva SA had a turnover of RON230 million in January-March 2023, up 36% on the year, and a profit of over RON42 million, almost nine times higher than RON5 million r...
Zentiva Group Appoints Zsolt Baranyai to Run Its Production Operations in Romania
Zentiva Group, held by private equity firm Advent International, has put Zsolt Baranyai in charge of the production operations in Romania, replacing Margareta Tanase, who retired after worki...
Zentiva Seeks RON100M Profit and RON850M Sales in 2023
Zentiva (SCD.RO), the largest pharmaceutical company listed on the Bucharest Stock Exchange, though with a low free float of merely 4%, is aiming for net sales of RON856 million and RON101.7...
Zentiva Appoints And Confirms Simona Cocos As Executive Board Chairwoman
Zentiva (SCD.RO), one of the largest pharmaceuticals producers in Romania, on Wednesday (March 22) announced in a stock market report that the company’s Board of Directors decided the appoin...
Zentiva SA Ends 2022 with RON753M Turnover, Up 10%, RON89M Net Profit, Down 15% from 2021
Pharmaceutical company in 2022 generated RON753 million turnover, up 10%, and RON89 million net profit, 15% lower than in 2021.